International Assets Investment Management, LLC Nurix Therapeutics, Inc. Transaction History
International Assets Investment Management, LLC
- $36.5 Billion
- Q3 2024
A detailed history of International Assets Investment Management, LLC transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, International Assets Investment Management, LLC holds 4,494 shares of NRIX stock, worth $118,057. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,494
Previous 375
1098.4%
Holding current value
$118,057
Previous $7.83 Million
97.44%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NRIX
# of Institutions
182Shares Held
66.4MCall Options Held
40.9KPut Options Held
106K-
Black Rock Inc. New York, NY6.82MShares$179 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.42MShares$116 Million6.02% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.99MShares$105 Million2.73% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$102 Million1.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.63MShares$95.2 Million0.0% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $1.24B
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...